BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31106985)

  • 21. Strategy for improving L-isoleucine production efficiency in Corynebacterium glutamicum.
    Wang X
    Appl Microbiol Biotechnol; 2019 Mar; 103(5):2101-2111. PubMed ID: 30663007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systems metabolic engineering of Corynebacterium glutamicum for high-level production of 1,3-propanediol from glucose and xylose.
    Li Z; Dong Y; Liu Y; Cen X; Liu D; Chen Z
    Metab Eng; 2022 Mar; 70():79-88. PubMed ID: 35038553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic engineering of Corynebacterium glutamicum S9114 to enhance the production of l-ornithine driven by glucose and xylose.
    Zhang B; Gao G; Chu XH; Ye BC
    Bioresour Technol; 2019 Jul; 284():204-213. PubMed ID: 30939382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterologous Production of Squalene from Glucose in Engineered Corynebacterium glutamicum Using Multiplex CRISPR Interference and High-Throughput Fermentation.
    Park J; Yu BJ; Choi JI; Woo HM
    J Agric Food Chem; 2019 Jan; 67(1):308-319. PubMed ID: 30558416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining protein and metabolic engineering strategies for high-level production of L-theanine in Corynebacterium glutamicum.
    Yang T; Zhang D; Cai M; Zhang H; Pan X; You J; Zhang X; Xu M; Rao Z
    Bioresour Technol; 2024 Feb; 394():130200. PubMed ID: 38103752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A New Strategy for Production of 5-Aminolevulinic Acid in Recombinant Corynebacterium glutamicum with High Yield.
    Yang P; Liu W; Cheng X; Wang J; Wang Q; Qi Q
    Appl Environ Microbiol; 2016 May; 82(9):2709-2717. PubMed ID: 26921424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Biosynthesis of Hyaluronic Acid Using Engineered Corynebacterium glutamicum Via Metabolic Pathway Regulation.
    Cheng F; Luozhong S; Guo Z; Yu H; Stephanopoulos G
    Biotechnol J; 2017 Oct; 12(10):. PubMed ID: 28869338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR interference-mediated metabolic engineering of Corynebacterium glutamicum for homo-butyrate production.
    Yoon J; Woo HM
    Biotechnol Bioeng; 2018 Aug; 115(8):2067-2074. PubMed ID: 29704438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biotechnological production of ectoine: current status and prospects.
    Chen J; Qiao D; Yuan T; Feng Y; Zhang P; Wang X; Zhang L
    Folia Microbiol (Praha); 2024 Apr; 69(2):247-258. PubMed ID: 37962826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic engineering of Corynebacterium glutamicum for glycolate production.
    Zahoor A; Otten A; Wendisch VF
    J Biotechnol; 2014 Dec; 192 Pt B():366-75. PubMed ID: 24486442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transport and metabolic engineering of the cell factory Corynebacterium glutamicum.
    Pérez-García F; Wendisch VF
    FEMS Microbiol Lett; 2018 Aug; 365(16):. PubMed ID: 29982619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From zero to hero--design-based systems metabolic engineering of Corynebacterium glutamicum for L-lysine production.
    Becker J; Zelder O; Häfner S; Schröder H; Wittmann C
    Metab Eng; 2011 Mar; 13(2):159-68. PubMed ID: 21241816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A giant market and a powerful metabolism: L-lysine provided by Corynebacterium glutamicum.
    Eggeling L; Bott M
    Appl Microbiol Biotechnol; 2015 Apr; 99(8):3387-94. PubMed ID: 25761623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of L-valine from metabolically engineered Corynebacterium glutamicum.
    Wang X; Zhang H; Quinn PJ
    Appl Microbiol Biotechnol; 2018 May; 102(10):4319-4330. PubMed ID: 29594358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in metabolic engineering of Corynebacterium glutamicum for bioproduction of value-added aromatic chemicals and natural products.
    Kogure T; Inui M
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8685-8705. PubMed ID: 30109397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolically engineered Corynebacterium glutamicum for bio-based production of chemicals, fuels, materials, and healthcare products.
    Becker J; Rohles CM; Wittmann C
    Metab Eng; 2018 Nov; 50():122-141. PubMed ID: 30031852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ectoine hyperproduction by engineered Halomonas bluephagenesis.
    Hu Q; Sun S; Zhang Z; Liu W; Yi X; He H; Scrutton NS; Chen GQ
    Metab Eng; 2024 Mar; 82():238-249. PubMed ID: 38401747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systems metabolic engineering of Corynebacterium glutamicum eliminates all by-products for selective and high-yield production of the platform chemical 5-aminovalerate.
    Rohles C; Pauli S; Gießelmann G; Kohlstedt M; Becker J; Wittmann C
    Metab Eng; 2022 Sep; 73():168-181. PubMed ID: 35917915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bio-based production of organic acids with Corynebacterium glutamicum.
    Wieschalka S; Blombach B; Bott M; Eikmanns BJ
    Microb Biotechnol; 2013 Mar; 6(2):87-102. PubMed ID: 23199277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9-coupled recombineering for metabolic engineering of Corynebacterium glutamicum.
    Cho JS; Choi KR; Prabowo CPS; Shin JH; Yang D; Jang J; Lee SY
    Metab Eng; 2017 Jul; 42():157-167. PubMed ID: 28649005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.